Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 15,636 $ 16,043
Accounts receivable and contract asset, net 16,134 12,921
Prepaid expenses and other current assets 2,504 2,172
Total current assets 34,274 31,136
Property and equipment, net 17,409 15,346
Operating lease right-of-use assets 2,323 882
Goodwill 2,816 2,811
Intangible assets, net 13,564 14,540
Other assets 1,918 1,605
Total assets 72,304 66,320
Current liabilities    
Accounts payable 1,587 1,192
Deferred revenue, short-term 26,235 24,174
Accrued expenses and other current liabilities 6,680 5,613
Total current liabilities 34,502 30,979
Deferred revenue, long-term 474 405
Other liabilities 3,513 631
Total liabilities 38,489 32,015
Commitments and contingencies (Note 19)
Stockholders' equity    
Preferred stock: $0.005 par value; 20,000,000 shares authorized; no shares issued and outstanding as of December 31, 2021 and 2020
Common stock: $0.005 par value; 500,000,000 shares authorized11,703,430 and 11,538,998 shares issued and outstanding as of December 31, 2021 and 2020, respectively 58 58
Additional paid-in capital 132,780 128,771
Accumulated deficit (98,785) (94,354)
Accumulated other comprehensive loss (238) (170)
Total stockholders' equity 33,815 34,305
Total liabilities and stockholders' equity $ 72,304 $ 66,320